UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 6, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 6, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $512.50 ($41,000) on August 6, 2026; holds 333,863 after (Indirect).
- Open-market sale: disposed of 625 Common Stock at $514.92 ($321,828) on August 6, 2026; holds 333,238 after (Indirect).
- Open-market sale: disposed of 263 Common Stock at $516.21 ($135,763) on August 6, 2026; holds 332,975 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $516.73 ($62,007) on August 6, 2026; holds 332,855 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $517.83 ($41,426) on August 6, 2026; holds 332,775 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $519.17 ($41,534) on August 6, 2026; holds 332,695 after (Indirect).
- Open-market sale: disposed of 633 Common Stock at $520.79 ($329,659) on August 6, 2026; holds 332,062 after (Indirect).
- Open-market sale: disposed of 719 Common Stock at $521.63 ($375,053) on August 6, 2026; holds 331,343 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $522.86 ($62,743) on August 6, 2026; holds 331,223 after (Indirect).
- Open-market sale: disposed of 182 Common Stock at $524.24 ($95,412) on August 6, 2026; holds 331,041 after (Indirect).
- Open-market sale: disposed of 824 Common Stock at $525.42 ($432,950) on August 6, 2026; holds 330,217 after (Indirect).
- Open-market sale: disposed of 1,357 Common Stock at $526.32 ($714,215) on August 6, 2026; holds 328,860 after (Indirect).
- Open-market sale: disposed of 1,283 Common Stock at $527.22 ($676,419) on August 6, 2026; holds 327,577 after (Indirect).
- Open-market sale: disposed of 875 Common Stock at $528.28 ($462,245) on August 6, 2026; holds 326,702 after (Indirect).
- Open-market sale: disposed of 759 Common Stock at $529.33 ($401,762) on August 6, 2026; holds 325,943 after (Indirect).
- Open-market sale: disposed of 680 Common Stock at $530.42 ($360,684) on August 6, 2026; holds 325,263 after (Indirect).
- Open-market sale: disposed of 400 Common Stock at $531.42 ($212,567) on August 6, 2026; holds 324,863 after (Indirect).
- Open-market sale: disposed of 420 Common Stock at $532.39 ($223,605) on August 6, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 6, 2026; holds 189,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,990,873 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-06 | Open-market sale | Common Stock | 80 | $513 | $41.0K | 333,863 |
| 2026-08-06 | Open-market sale | Common Stock | 625 | $515 | $321.8K | 333,238 |
| 2026-08-06 | Open-market sale | Common Stock | 263 | $516 | $135.8K | 332,975 |
| 2026-08-06 | Open-market sale | Common Stock | 120 | $517 | $62.0K | 332,855 |
| 2026-08-06 | Open-market sale | Common Stock | 80 | $518 | $41.4K | 332,775 |
| 2026-08-06 | Open-market sale | Common Stock | 80 | $519 | $41.5K | 332,695 |
| 2026-08-06 | Open-market sale | Common Stock | 633 | $521 | $329.7K | 332,062 |
| 2026-08-06 | Open-market sale | Common Stock | 719 | $522 | $375.1K | 331,343 |
| 2026-08-06 | Open-market sale | Common Stock | 120 | $523 | $62.7K | 331,223 |
| 2026-08-06 | Open-market sale | Common Stock | 182 | $524 | $95.4K | 331,041 |
| 2026-08-06 | Open-market sale | Common Stock | 824 | $525 | $433.0K | 330,217 |
| 2026-08-06 | Open-market sale | Common Stock | 1,357 | $526 | $714.2K | 328,860 |
| 2026-08-06 | Open-market sale | Common Stock | 1,283 | $527 | $676.4K | 327,577 |
| 2026-08-06 | Open-market sale | Common Stock | 875 | $528 | $462.2K | 326,702 |
| 2026-08-06 | Open-market sale | Common Stock | 759 | $529 | $401.8K | 325,943 |
| 2026-08-06 | Open-market sale | Common Stock | 680 | $530 | $360.7K | 325,263 |
| 2026-08-06 | Open-market sale | Common Stock | 400 | $531 | $212.6K | 324,863 |
| 2026-08-06 | Open-market sale | Common Stock | 420 | $532 | $223.6K | 324,443 |
| 2026-08-06 | Option exercise/conversion | Stock Option | 9,500 | — | — | 189,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Option exercise/conversion (9,500 shares) |
| 2026-08-06 | Open-market sale (80 shares) |
| 2026-08-06 | Open-market sale (625 shares) |
| 2026-08-06 | Open-market sale (263 shares) |
| 2026-08-06 | Open-market sale (120 shares) |
| 2026-08-06 | Open-market sale (80 shares) |
| 2026-08-06 | Open-market sale (80 shares) |
| 2026-08-06 | Open-market sale (633 shares) |
| 2026-08-06 | Open-market sale (719 shares) |
| 2026-08-06 | Open-market sale (120 shares) |
| 2026-08-06 | Open-market sale (182 shares) |
| 2026-08-06 | Open-market sale (824 shares) |
| 2026-08-06 | Open-market sale (1,357 shares) |
| 2026-08-06 | Open-market sale (1,283 shares) |
| 2026-08-06 | Open-market sale (875 shares) |
| 2026-08-06 | Open-market sale (759 shares) |
| 2026-08-06 | Open-market sale (680 shares) |
| 2026-08-06 | Open-market sale (400 shares) |
| 2026-08-06 | Open-market sale (420 shares) |
| 2026-08-06 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.